Clinical Trial Update: Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating granisetron to prevent chemotherapy-induced nausea and vomiting in adults with malignant disease, including unspecified solid tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Granisetron (granisetron)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | Status: UNKNOWN